# Shattuck Labs Inc. (STTK) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $6.79, market value $681 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Shattuck Labs Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 681.5×**. Each dollar of revenue is priced at 681.5×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 5.4×**. The shares trade at 5.4× book value; most of the value is in earnings power and intangibles rather than the balance sheet.

## Profitability
- **Return on equity: -59.2%**. Return on equity is negative because earnings are negative.
- **Return on assets: -57.8%**. Each dollar of assets produces -57.8% of profit.

## Growth
- **Revenue growth (1 yr): -82.5%** (3-yr 15.3%/yr, 5-yr -36.8%/yr). Revenue fell 82.5% over the last year, against -36.8% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 53.0%**. Earnings per share rose 53.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 11.70** (quick 11.70). Current assets cover the next year's liabilities 11.70 times.
- **Altman Z-score: 47.75**. A Z-score of 47.75 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Shattuck Labs Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (9 analysts). 9 analysts cover Shattuck Labs Inc.; the consensus is strong_buy, with an average price target of $14.67 (+116% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 349.7%** (YTD 86.0%, 3-mo 48.3%). The shares are up 349.7% over twelve months including dividends.
- **From 52-week high: -18.5%** (304.2% above the low). Trading 18% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 1.53** (volatility 89%). Beta of 1.53 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=STTK · Page: https://foliofundamentals.com/stocks/sttk

Not investment advice.